Adenomatous polyposis coli in cancer and therapeutic implications

Autor: Rachel Royfman, Olivia Noe, Danae Hamouda, Austin Campbell, Louis Filipiak, Laura Stanbery, John Nemunaitis, Leslie L Lin

Publikováno v: Oncology Reviews, Vol 15, Iss 1 (2021)
Oncology Reviews

Inactivating mutations of the adenomatous polyposis coli (APC) gene and consequential upregulation of the Wnt signaling pathway are critical initiators in the development of colorectal cancer (CRC), the third most common cancer in the United States f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36c3fb2dace97bf0df23b816d973ea34
https://oncologyreviews.org/site/article/view/534

Targeted Combination of Poly(ADP-ribose) Polymerase Inhibitors and Immune Checkpoint Inhibitors Lacking Evidence of Benefit: Focus in Ovarian Cancer.

Autor: Bailey M; Department of Medicine, University of Toledo, Toledo, OH 43614, USA., Morand S; Department of Medicine, University of Toledo, Toledo, OH 43614, USA., Royfman R; Department of Medicine, University of Toledo, Toledo, OH 43614, USA., Lin L; Department of Medicine, University of Toledo, Toledo, OH 43614, USA., Singh A; Department of Medicine, University of Toledo, Toledo, OH 43614, USA., Stanbery L; Gradalis, Inc., Dallas, TX 75006, USA., Walter A; Gradalis, Inc., Dallas, TX 75006, USA.; Department of Gynecologic Oncology, Promedica, Toledo, OH 43614, USA., Hamouda D; Department of Medicine, University of Toledo, Toledo, OH 43614, USA., Nemunaitis J; Gradalis, Inc., Dallas, TX 75006, USA.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 09; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 09.

NF-κB Signaling in Tumor Pathways Focusing on Breast and Ovarian Cancer.

Autor: Devanaboyina M; Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States., Kaur J; Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States., Whiteley E; Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States., Lin L; Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States., Einloth K; Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States., Morand S; Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States., Stanbery L; Gradalis, Inc., Carrollton, TX, United States., Hamouda D; Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States., Nemunaitis J; Gradalis, Inc., Carrollton, TX, United States.

Publikováno v: Oncology reviews [Oncol Rev] 2022 Oct 03; Vol. 16, pp. 10568. Date of Electronic Publication: 2022 Oct 03 (Print Publication: 2022).